Gotowa bibliografia na temat „Biosafety”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Spis treści
Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Biosafety”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Artykuły w czasopismach na temat "Biosafety"
Truchaud, A., P. Schnipelsky, H. L. Pardue, J. Place i K. Ozawa. "Increasing the biosafety of analytical systems in the clinical laboratory". Journal of Automatic Chemistry 16, nr 2 (1994): 67–70. http://dx.doi.org/10.1155/s1463924694000076.
Pełny tekst źródłaVoss, Andreas, Sigfrido Rangel-Frausto i Jan Kluytmans. "Biosafety". Infection Control & Hospital Epidemiology 20, nr 9 (wrzesień 1999): 644. http://dx.doi.org/10.1017/s0195941700071253.
Pełny tekst źródłaYu, Yingjie, Jianxun Ding, Yunhao Zhou, Haihua Xiao i Guizhen Wu. "Biosafety chemistry and biosafety materials: A new perspective to solve biosafety problems". Biosafety and Health 4, nr 1 (luty 2022): 15–22. http://dx.doi.org/10.1016/j.bsheal.2022.01.001.
Pełny tekst źródłaGalyukova, M. I. "Biosafety Architectonics". Lex Russica 75, nr 10 (18.10.2022): 54–67. http://dx.doi.org/10.17803/1729-5920.2022.191.10.054-067.
Pełny tekst źródłaDesrosiers, R., i E. Hunter. "AIDS biosafety". Science 252, nr 5010 (31.05.1991): 1231. http://dx.doi.org/10.1126/science.1953906.
Pełny tekst źródłaByers, Karen. "Biosafety Tips". Applied Biosafety 7, nr 2 (czerwiec 2002): 94–95. http://dx.doi.org/10.1177/153567600200700209.
Pełny tekst źródłaByers, Karen B. "Biosafety Tips". Applied Biosafety 7, nr 3 (wrzesień 2002): 164–66. http://dx.doi.org/10.1177/153567600200700311.
Pełny tekst źródłaByers, Karen B. "Biosafety Tips". Applied Biosafety 7, nr 4 (grudzień 2002): 250–53. http://dx.doi.org/10.1177/153567600200700408.
Pełny tekst źródłaByers, Karen B. "Biosafety Tips". Applied Biosafety 8, nr 1 (marzec 2003): 27–29. http://dx.doi.org/10.1177/153567600300800108.
Pełny tekst źródłaByers, Karen B. "Biosafety Tips". Applied Biosafety 8, nr 2 (czerwiec 2003): 81–84. http://dx.doi.org/10.1177/153567600300800207.
Pełny tekst źródłaRozprawy doktorskie na temat "Biosafety"
Margaritis, D. "Biosafety and biosecurity : design, construction and facility management". Thesis, University College London (University of London), 2017. http://discovery.ucl.ac.uk/1551533/.
Pełny tekst źródłaLoosen, Katja. "Das Biosafety-Protokoll von Cartagena zwischen Umweltvölkerrecht und Welthandelsrecht". Berlin Logos-Verl, 2005. http://deposit.ddb.de/cgi-bin/dokserv?id=2748303&prov=M&dok_var=1&dok_ext=htm.
Pełny tekst źródłaLoosen, Katja. "Das Biosafety-Protokoll von Cartagena zwischen Umweltvölkerrecht und Welthandelsrecht /". Berlin : Logos Verlag, 2006. http://www.gbv.de/dms/spk/sbb/recht/toc/505260972.pdf.
Pełny tekst źródłaDu, Plessis Marthinus Johannes. "The international political economy of the Cartagena Protocol on biosafety". Thesis, Stellenbosch : Stellenbosch University, 2001. http://hdl.handle.net/10019.1/52543.
Pełny tekst źródłaENGLISH ABSTRACT: The development of the global biotechnology industry largely coincided with the development of the US biotechnology industry. This resulted in this industry's oligopolistic and centralised nature where only a few multinational chemical and pharmaceutical companies control most biotechnology processes and production of commodities emanating from these processes. The governance of biotechnology has, until recently, been dominated by state actors who have endeavoured to secure national interests, including those of large multinational corporations (MNCs) based within their boundaries. The technological ability of developed states to exploit and use unevenly distributed resources to their advantage means that an uneven relationship exists between these and poor developing countries. This has been highlighted by differences in public opinion about the role and application of biotechnology in society. While some opinions favour the use and application of biotechnology to enhance food supplies and boost production levels and trade, other opinions caution against the possible hazards that genetically manipulated organisms (GMOs) hold for the environment and human existence. The commercialisation of biotechnology has resulted in the exponential growth of genetically manipulated crops in especially the United States and countries like Argentina and Canada. These countries produce large surpluses of staple grains such as corn and soya and try to sell these to countries with food supply problems. The clash in commercial interests stemming from developed countries' insistence on the protection of intellectual property rights (IPR) on genetically manipulated (GM) seeds has caused considerable conflict with poor farmers who will not be able to sustain their livelihoods if they cannot save seeds for future harvests. This is one aspect of the problems surrounding the protection of knowledge products that is exacerbated by the scientific uncertainty pertaining to the risk involved with biotechnology. While some observers agitate for precaution with the use of GMOs, others feel that a lack of scientific proof of harm is sufficient grounds for proceeding with developments in biotechnology. Conversely, there are some that feel that biotechnology is market driven instead of human needs driven, ultimately resulting in developing countries receiving very little benefit from it. The Cartagena Protocol on biosafety was drafted to address some of the difficulties involved with the transboundary movement of GMOs. Although it holds very specific advantages for developing countries, as a regulatory framework it is limited in its scope and application. Developing countries are limited in their policy options to address their need to protect biodiversity and secure their food supply. This means that considerable challenges and constraints await these countries in utilising global governance of public goods and building their human and technological capacities.
AFRIKAANSE OPSOMMING: Die ontwikkeling van die globale biotegnologie-industrie het grootliks saamgeval met die ontwikkeling van die Verenigde State se biotegnologie-industrie. Dit het aanleiding gegee tot hierdie industrie se oligopolistiese en gesentraliseerde aard waar slegs enkele multinasionale chemiese en farmaseutiese maatskappye die meeste biotegnologie prosesse en die vervaardiging van kommoditeite uit daardie prosesse beheer. Die regering van biotegnologie was tot onlangs oorheers deur staatsakteurs wie gepoog het om nasionale belange te beskerm, insluitend die belange van multinasionale korporasies (MNK) wat vanuit hulle grondgebied funksioneer. Die tegnologiese vermoë van ontwikkelde state om oneweredig verspreide hulpbronne tot eie gewin te benut beteken dat 'n ongelyke verhouding bestaan tussen hierdie en arm ontwikkelende state. Dit word beklemtoon deur verskille in openbare mening oor die rol en aanwending van biotegnologie in die samelewing. Terwyl sekere opinies ten gunste van die aanwending van biotegnologie vir die verbetering van voedselbronne en produksievlakke en handel is, dui ander opinies op die moontlike gevare wat geneties gemanipuleerde organismes (GMOs) vir die omgewing en menslike voortbestaan inhou. Die kommersialisering van biotegnologie het gelei tot die eksponensiële groei van geneties gemanipuleerde gewasse in veral die Verenigde State en state soos Argentinië en Kanada. Hierdie state produseer groot hoeveelhede stapelgrane soos mielies en soja en poog om dit te verkoop aan state met voedselvoorsieningsprobleme. Die botsing in kommersiële belange wat spruit uit ontwikkelde state se aandrang op die beskerming van intellektuele eiendomsreg op geneties gemanipuleerde saad veroorsaak beduidende konflik met arm landbouers wie nie hulle lewensonderhoud kan verseker as hulle nie saad kan berg vir toekomstige saaiseisoene nie. Dit is een aspek van die problematiek rondom die beskerming van kennisprodukte wat vererger word deur die wetenskaplike onsekerheid wat gepaard gaan met die risiko's van biotegnologie. Terwyl sekere waarnemers vir waaksaamheid pleit in die gebruik van GMOs, is daar ander wat voel dat 'n gebrek aan wetenskaplike bewyse van skade genoegsame gronde is vir die voortsetting van ontwikkelings in biotegnologie. Insgelyks is daar diegene wat meen dat biotegnologie markgedrewe in plaas van menslike behoefte gedrewe is, wat uiteindelik daartoe lei dat ontwikkelende state baie min voordeel daaruit trek. Die Kartagena Protokoloor bioveiligheid is opgestel om van die probleme betrokke by die oorgrens verskuiwing van GMOs aan te spreek. Hoewel dit spesifieke voordele vir ontikkelende state inhou is dit as reguleringsraamwerk beperk in omvang en aanwending. Ontwikkelende state het beperkte beleidsopsies om hulle behoefte om biodiversiteit te beskerm en voedselvoorsiening te verseker, aan te spreek. Dit beteken dat beduidende uitdagings en beperkings hierdie state in die benutting van globale regering van openbare goedere vir die bou van menslike en tegnologiese kapasiteite in die gesig staar.
Agutter, Paula Anne. "Computational fluid dynamics as a tool for quantitative biosafety studies". Thesis, University College London (University of London), 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.286672.
Pełny tekst źródłaモニカ, ラコヴィタ, i Monica Racovita. "Policies of genetically modified crops in India: food security and biosafety politics". Thesis, https://doors.doshisha.ac.jp/opac/opac_link/bibid/BB12252585/?lang=0, 2011. https://doors.doshisha.ac.jp/opac/opac_link/bibid/BB12252585/?lang=0.
Pełny tekst źródłaJoy, Faida. "Biosafety Regulation: a comparative analysis of the South African and Ugandan experience". Master's thesis, University of Cape Town, 2014. http://hdl.handle.net/11427/4478.
Pełny tekst źródłaKingiri, Ann Njoki. "An enquiry into biosafety regulations implementation in Kenya : perspectives and roles of scientists". Thesis, Open University, 2009. http://oro.open.ac.uk/54654/.
Pełny tekst źródłaCuevas, Edmund B. "Biosecurity and biosafety systems in the Philippines and New Zealand : A cross-case analysis". Thesis, University of Canterbury. Forestry, 2005. http://hdl.handle.net/10092/6883.
Pełny tekst źródłaWint, Sandra Marie Elizabeth. "Requirements for national capacity building under the framework of the Cartagena Protocol on Biosafety". Thesis, University of Sussex, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.413315.
Pełny tekst źródłaKsiążki na temat "Biosafety"
Egziabher, Tewolde Berhan Gebre. Biosafety & biodiversity. Addis Ababa: Environmental Protection Authority, 2010.
Znajdź pełny tekst źródłaHeinsohn, Patricia A., Robert R. Jacobs i Beth A. Concoby, red. Biosafety Reference Manual. 2700 Prosperity Ave., Suite 250 Fairfax, VA 22031: American Industrial Hygiene Association, 1995. http://dx.doi.org/10.3320/978-0-932627-65-0.
Pełny tekst źródłaBrandenberg, Oliver. Biosafety resource book. Rome: Food and Agriculture Organization of the United Nations, 2011.
Znajdź pełny tekst źródłaY, Richmond Jonathan, i American Biological Safety Association, red. Anthology of biosafety. Mundelein, IL: American Biological Safety Association, 1999.
Znajdź pełny tekst źródła1940-, Kennedy M. E., i Laboratory Centre for Disease Control (Canada), red. Laboratory biosafety guidelines. Wyd. 2. Ottawa: Laboratory Centre for Disease Control, Health Canada, 1996.
Znajdź pełny tekst źródłaLaboratory Centre for Disease Control (Canada), Canada. Dept. of National Health and Welfare. i Medical Research Council (Canada), red. Laboratory biosafety guidelines. Ottawa, Ont: Dept. of National Health and Welfare, 1990.
Znajdź pełny tekst źródłaBiosafety Act, 2002. Zomba, Malawi: Govt. Printer, 2003.
Znajdź pełny tekst źródłaElizabeth, Hodson de Jaramillo, Sensi Alessandra i Food and Agriculture Organization of the United Nations, red. Biosafety resource book. Rome: Food and Agriculture Organization of the United Nations, 2011.
Znajdź pełny tekst źródłaHambleton, P., J. Melling i T. T. Salusbury, red. Biosafety in Industrial Biotechnology. Dordrecht: Springer Netherlands, 1994. http://dx.doi.org/10.1007/978-94-011-1352-6.
Pełny tekst źródłaSchmidt, Erwin R., i Thomas Hankeln, red. Transgenic Organisms and Biosafety. Berlin, Heidelberg: Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-642-61460-6.
Pełny tekst źródłaCzęści książek na temat "Biosafety"
Falkner, Robert. "Biosafety". W Essential Concepts of Global Environmental Governance, 24. Second edition. | Abingdon, Oxon; New York: Routledge, 2021.: Routledge, 2020. http://dx.doi.org/10.4324/9780367816681-10.
Pełny tekst źródłaGupta, Aarti. "Biotechnology and Biosafety". W The Handbook of Global Climate and Environment Policy, 89–106. Oxford, UK: John Wiley & Sons Ltd, 2013. http://dx.doi.org/10.1002/9781118326213.ch6.
Pełny tekst źródłaGupta, Varsha, Manjistha Sengupta, Jaya Prakash i Baishnab Charan Tripathy. "Biosafety and Bioethics". W Basic and Applied Aspects of Biotechnology, 503–20. Singapore: Springer Singapore, 2016. http://dx.doi.org/10.1007/978-981-10-0875-7_24.
Pełny tekst źródłaKavanagh, Vanessa, i Linda Hall. "Biology and Biosafety". W Triticale, 3–13. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-22551-7_1.
Pełny tekst źródłaMertsching, Jürgen. "Biosafety und Biosecurity". W Handbuch für mikrobiologische Laboratorien der Schutz- und Sicherheitsstufen 1–4, 1–31. Wiesbaden: Springer Fachmedien Wiesbaden, 2022. http://dx.doi.org/10.1007/978-3-658-34105-3_1.
Pełny tekst źródłaFleming, Diane O. "Prudent Biosafety Practices". W Biological Safety, 361–71. Washington, DC, USA: ASM Press, 2014. http://dx.doi.org/10.1128/9781555815899.ch19.
Pełny tekst źródłaten Have, Henk, i Maria do Céu Patrão Neves. "Safety (See Biosafety)". W Dictionary of Global Bioethics, 939. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-54161-3_463.
Pełny tekst źródłaten Have, Henk, i Maria do Céu Patrão Neves. "Biosafety (See Biosecurity)". W Dictionary of Global Bioethics, 199. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-54161-3_96.
Pełny tekst źródłaSinha, Archana, i Pramod Kumar Pandey. "Biosafety and Hygiene". W Breeding and Culture of Freshwater Ornamental Fish, 195–208. London: CRC Press, 2023. http://dx.doi.org/10.1201/9781003456858-12.
Pełny tekst źródłaLudlow, Karinne, Stuart J. Smyth i José Falck-Zepeda. "Ensuring Functional Biosafety Systems". W Socio-Economic Considerations in Biotechnology Regulation, 277–93. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-9440-9_19.
Pełny tekst źródłaStreszczenia konferencji na temat "Biosafety"
BAKANIDZE, LELA, PAATA IMNADZE, SHOTA TSANAVA i NIKOLOZ TSERTSVADZE. "NEW GEORGIAN LEGISLATION ON BIOSAFETY". W The 32nd Session of International Seminars and International Collaboration. WORLD SCIENTIFIC, 2005. http://dx.doi.org/10.1142/9789812701787_0025.
Pełny tekst źródłaKassirov, I. S., i A. S. Dolgova. "DEVELOPMENT OF EXPRESSION CASSETTE FOR EFFICIENT PRODUCTION OF NS1 PROTEIN OF THE DENGE VIRUS". W Molecular Diagnostics and Biosafety. Federal Budget Institute of Science 'Central Research Institute for Epidemiology', 2020. http://dx.doi.org/10.36233/978-5-9900432-9-9-209.
Pełny tekst źródłaNagornykh, A. M., A. I. Tyumentsev, M. A. Tyumentseva i V. G. Akimkin. "ANALYSIS OF PROMISING OPPORTUNITIES FOR THE USE OF GENOME EDITING TECHNOLOGIES IN CATTLE AND PIG INDUSTRY IN TERMS OF SURVIVAL OF YOUNG ANIMALS IN THE NEONATAL PERIOD". W Molecular Diagnostics and Biosafety. Federal Budget Institute of Science 'Central Research Institute for Epidemiology', 2020. http://dx.doi.org/10.36233/978-5-9900432-9-9-104.
Pełny tekst źródłaBelyaeva, V. V., N. V. Kozyrina, U. А. Kuimova, М. D. Goliusova i А. N. Narkevich. "BEHAVIOURAL PATTERNS FOR PROPHYLAXIS OF COVID-19: SURVEY OF MEDICAL PROFESSIONALS AND AIDS PATIENTS". W Molecular Diagnostics and Biosafety. Federal Budget Institute of Science 'Central Research Institute for Epidemiology', 2020. http://dx.doi.org/10.36233/978-5-9900432-9-9-125.
Pełny tekst źródłaTerekhova, M. I., E. V. Rogacheva, I. A. Derevyanchenko i L. A. Kraeva. "WHOLE-GENOME SEQUENCING-BASED ANTIBIOTIC RESISTANCE PROFILE OF LISTERIA MONOCYTOGENES STRAINS FROM SAINT-PETERSBURG AND THE VOLOGDA REGION". W Molecular Diagnostics and Biosafety. Federal Budget Institute of Science 'Central Research Institute for Epidemiology', 2020. http://dx.doi.org/10.36233/978-5-9900432-9-9-109.
Pełny tekst źródłaTyumentsev, A. I., M. A. Tyumentseva i V. G. Akimkin. "DEVELOPMENT OF APPROACHES FOR ENDOTOXIN REMOVAL FROM PROTEIN PREPARATIONS ON THE EXAMPLE OF NUCLEASES OF THE CRISPR/CAS SYSTEM". W Molecular Diagnostics and Biosafety. Federal Budget Institute of Science 'Central Research Institute for Epidemiology', 2020. http://dx.doi.org/10.36233/978-5-9900432-9-9-113.
Pełny tekst źródłaTyumentseva, M. A., A. I. Tyumentsev i V. G. Akimkin. "DEVELOPMENT OF APPROACHES FOR DETECTION OF GENOME-INTEGRATED PROVIRAL DNA OF THE HUMAN IMMUNODEFICIENCY VIRUS (HIV-1) IN ULTRA LOW CONCENTRATIONS USING THE CRISPR/CAS SYSTEM". W Molecular Diagnostics and Biosafety. Federal Budget Institute of Science 'Central Research Institute for Epidemiology', 2020. http://dx.doi.org/10.36233/978-5-9900432-9-9-118.
Pełny tekst źródłaFaizuloev, E. B., A. N. Kaira, T. R. Uzbekov, A. A. Poromov, E. A. Volynskaya, O. A. Svitich i V. V. Zverev. "GENETIC STRUCTURE OF HIGH AND LOW RISK HUMAN PAPILLOMAVIRUSES CIRCULATING IN THE RUSSIAN FEDERATION". W Molecular Diagnostics and Biosafety. Federal Budget Institute of Science 'Central Research Institute for Epidemiology', 2020. http://dx.doi.org/10.36233/978-5-9900432-9-9-123.
Pełny tekst źródłaStashko, T. V. "MAIN CLINICAL AND DEMOGRAPHIC COVID-19 INDICATORS DURING THE MAXIMUM SPREAD SARS-COV-2 PANDEMIC BY THE EXAMPLE OF THE INFECTIOUS HOSPITAL IN THE MOSCOW OBLAST". W Molecular Diagnostics and Biosafety. Federal Budget Institute of Science 'Central Research Institute for Epidemiology', 2020. http://dx.doi.org/10.36233/978-5-9900432-9-9-176.
Pełny tekst źródłaBugorkova, S. A., E. A. Chumachkova, A. L. Kravtsov, S. A. Portenko, V. A. Kozhevnikov, A. Yu Goncharova, E. V. Naidenova, O. V. Kedrova, E. S. Kazakova i S. A. Shcherbakova. "IMMUNOLOGICAL DISORDERS IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA DURING THE COVID-19 EPIDEMIC IN SARATOV OBLAST". W Molecular Diagnostics and Biosafety. Federal Budget Institute of Science 'Central Research Institute for Epidemiology', 2020. http://dx.doi.org/10.36233/978-5-9900432-9-9-127.
Pełny tekst źródłaRaporty organizacyjne na temat "Biosafety"
King, Bruce W. Biosafety Manual. Office of Scientific and Technical Information (OSTI), maj 2010. http://dx.doi.org/10.2172/983284.
Pełny tekst źródłaSiegel, Dina. Principles of Biosafety. Office of Scientific and Technical Information (OSTI), listopad 2022. http://dx.doi.org/10.2172/1900435.
Pełny tekst źródłaCaskey, Susan Adele, Jennifer M. Gaudioso, Reynolds Mathewson Salerno, Stefan M. Wagner, Mika Shigematsu, George Risi, Joe Kozlovac, Vibeke Halkjaer-Knudsen i Esmeralda Prat. Biosafety Risk Assessment Methodology. Office of Scientific and Technical Information (OSTI), październik 2010. http://dx.doi.org/10.2172/1325209.
Pełny tekst źródłaDickens, Brian Scott, Melanie Ann Chavez, Donovan J. Heimer, Ryan Knudsen i Celina Carmelita Velasquez. Biosafety Level 3 Recon Training. Office of Scientific and Technical Information (OSTI), kwiecień 2017. http://dx.doi.org/10.2172/1352397.
Pełny tekst źródłaSiegel, Dina. Principles of Biosafety Course # 31701. Office of Scientific and Technical Information (OSTI), wrzesień 2022. http://dx.doi.org/10.2172/1887109.
Pełny tekst źródłaSchuerger, Caroline, Sara Abdulla i Anna Puglisi. Mapping Biosafety Level-3 Laboratories by Publications. Center for Security and Emerging Technology, sierpień 2022. http://dx.doi.org/10.51593/20220019.
Pełny tekst źródłaRevill, James, i Kai Ilchmann. Assessing the SecBio Platform Proposal for the Biological Weapons Convention. UNIDIR, grudzień 2022. http://dx.doi.org/10.37559/wmd/22/bwc/04.
Pełny tekst źródłaSerna, Kassandra, i Giulio M. Mancini. Draft Libya Legislative Framework for Biosafety and Biosecurity. Office of Scientific and Technical Information (OSTI), grudzień 2014. http://dx.doi.org/10.2172/1173190.
Pełny tekst źródłaResearch Institute (IFPRI), International Food Policy. Socioeconomic considerations in biosafety decisionmaking Methods and implementation. Washington, DC: International Food Policy Research Institute, 2013. http://dx.doi.org/10.2499/9780896292079.
Pełny tekst źródłaSiegel, Dina Mary. Biosafety- A Regulatory Primer for DOE/NNSA Sites. Office of Scientific and Technical Information (OSTI), maj 2017. http://dx.doi.org/10.2172/1356119.
Pełny tekst źródła